Search research articles
Contact Us
Filters
Showing results (451-460 of 2,090) with videos related to
Page
of 209
Sort By:
RMD Open
|
April 12, 2024
Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
Yun-Kyoung Song, Jaehee Lee, Junwoo Jo, et al.
RMD Open
|
April 5, 2024
Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register
Tatjana Rudi, Vera Zietemann, Yvette Meissner, et al.
RMD Open
|
February 23, 2024
New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis
Alessandro Tomelleri, Christian Dejaco
RMD Open
|
February 27, 2024
Window of opportunity in psoriatic arthritis: the earlier the better?
Selinde V J Snoeck Henkemans, Pascal H P de Jong, Jolanda J Luime, et al.
RMD Open
|
February 21, 2024
Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway
Ingebjørg Tronstad, Mari Hoff, Julie Horn, et al.
RMD Open
|
February 22, 2024
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, et al.
RMD Open
|
February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Laura C Coates, Robert Landewé, Iain B McInnes, et al.
RMD Open
|
February 5, 2024
Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
Anna Zubrzycka-Sienkiewicz, Kamilla Klama, Martin Ullmann, et al.
RMD Open
|
February 2, 2024
Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study
Kirstine Amris, Rikke Ibsen, Pernille Hurup Duhn, et al.
RMD Open
|
January 31, 2024
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis
Benoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, et al.
Page
of 209
Search research articles
Search
Showing results (451-460 of 2,090) with videos related to
Sort By:
Page
of 209
RMD Open
|
April 12, 2024
Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
Yun-Kyoung Song, Jaehee Lee, Junwoo Jo, et al.
RMD Open
|
April 5, 2024
Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register
Tatjana Rudi, Vera Zietemann, Yvette Meissner, et al.
RMD Open
|
February 23, 2024
New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis
Alessandro Tomelleri, Christian Dejaco
RMD Open
|
February 27, 2024
Window of opportunity in psoriatic arthritis: the earlier the better?
Selinde V J Snoeck Henkemans, Pascal H P de Jong, Jolanda J Luime, et al.
RMD Open
|
February 21, 2024
Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway
Ingebjørg Tronstad, Mari Hoff, Julie Horn, et al.
RMD Open
|
February 22, 2024
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, et al.
RMD Open
|
February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Laura C Coates, Robert Landewé, Iain B McInnes, et al.
RMD Open
|
February 5, 2024
Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
Anna Zubrzycka-Sienkiewicz, Kamilla Klama, Martin Ullmann, et al.
RMD Open
|
February 2, 2024
Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study
Kirstine Amris, Rikke Ibsen, Pernille Hurup Duhn, et al.
RMD Open
|
January 31, 2024
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis
Benoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, et al.
Page
of 209